Results from a phase I study of MK-1308 (anti-CTLA-4) plus pembrolizumab in previously treated advanced small cell lung cancerB. C. Cho,K. Yoh,J. Bar,A. Nagrial,D. R. Spigel,M. Gutierrez,D-W. Kim,D. Kotasek,D. Rasco,J. Niu,M. Satouchi,M-J. Ahn, D. H. Lee,C. Maurice-Dror, S. Siddiqi,X. Li,J. Cyrus, R. A. Altura,R. PeretsAnnals of Oncology(2019)引用 4|浏览30暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要